FirePlex® platform: for true multiplexing


Quantifying miRNA and protein biomarkers directly from challenging sample types with FirePlex Technology

FirePlex assays combine innovative FirePlex particle technology along with Abcam’s optimized matched antibody pairs for analyte detection, offering the highest standards in sensitivity and specificity.

Talk with our team


Abcam will process your personal data in strict accordance with its privacy policy which can be found here. This will include sending you updates about Abcam, our products, and resources we think would be of interest to you. You can unsubscribe and manage your marketing preferences by clicking the link at the bottom of every email we send.

Multiplexing has never been easier

  • Profiling Service

    Design experiments that meet your research needs and budget

  • miRNA biomarkers

    Assays validated with complex biofluids, FFPEs, and tissue samples

  • Cytokine quantification

    Only 12 µL of biofluid or 5um tissue input needed, for up to 70 analytes

  • High-Throughput screening

    No-wash assay format, automatable workflow

Learn about the benefits with our 1-minute video

Learn more about FirePlex

  • How does it work?

    Everything you need to know about our patented FirePlex hydrogel particle technology.

    Learn more

  • How does it compare?

    See how FirePlex compares to other available technologies with our technical comparison.

    Read the technical note

  • How are other scientists using it?

    Researchers around the globe are forging new biomedical frontiers with FirePlex miRNA and immunoassays.

    View publications

  • Maria A.S. Broggi, PhD

    “As always with FirePlex I am very happy for the speed and the quality of the data provided and support. Is not only fundamental to understand and trust the experimental procedure, but is also important to be able to stay in touch with the FirePlex team (in my case mainly Michael Tackett this time) that helps you with all the problems and concerns one might have during the analysis of the data. All of this was always done with high efficiency and availability.”

    Maria A.S. Broggi, PhD, Laboratory of Lymphatic and Cancer Bioengineering, Institute of Bioengineering, Swiss Federal Institute of Technology

Talk with our team


Abcam will process your personal data in strict accordance with its privacy policy which can be found here. This will include sending you updates about Abcam, our products, and resources we think would be of interest to you. You can unsubscribe and manage your marketing preferences by clicking the link at the bottom of every email we send.